338 related articles for article (PubMed ID: 23630290)
1. In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction.
Shima F; Yoshikawa Y; Ye M; Araki M; Matsumoto S; Liao J; Hu L; Sugimoto T; Ijiri Y; Takeda A; Nishiyama Y; Sato C; Muraoka S; Tamura A; Osoda T; Tsuda K; Miyakawa T; Fukunishi H; Shimada J; Kumasaka T; Yamamoto M; Kataoka T
Proc Natl Acad Sci U S A; 2013 May; 110(20):8182-7. PubMed ID: 23630290
[TBL] [Abstract][Full Text] [Related]
2. Discovery of small-molecule Ras inhibitors that display antitumor activity by interfering with Ras·GTP-effector interaction.
Shima F; Yoshikawa Y; Matsumoto S; Kataoka T
Enzymes; 2013; 34 Pt. B():1-23. PubMed ID: 25034098
[TBL] [Abstract][Full Text] [Related]
3. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
[TBL] [Abstract][Full Text] [Related]
4. Molecular Basis for Allosteric Inhibition of GTP-Bound H-Ras Protein by a Small-Molecule Compound Carrying a Naphthalene Ring.
Matsumoto S; Hiraga T; Hayashi Y; Yoshikawa Y; Tsuda C; Araki M; Neya M; Shima F; Kataoka T
Biochemistry; 2018 Sep; 57(36):5350-5358. PubMed ID: 30141910
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RAS: proven and potential vulnerabilities.
Zuberi M; Khan I; O'Bryan JP
Biochem Soc Trans; 2020 Oct; 48(5):1831-1841. PubMed ID: 32869838
[TBL] [Abstract][Full Text] [Related]
6. A RasGTP-induced conformational change in C-RAF is essential for accurate molecular recognition.
Hibino K; Shibata T; Yanagida T; Sako Y
Biophys J; 2009 Sep; 97(5):1277-87. PubMed ID: 19720015
[TBL] [Abstract][Full Text] [Related]
7. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
[TBL] [Abstract][Full Text] [Related]
8. A distinct class of dominant negative Ras mutants: cytosolic GTP-bound Ras effector domain mutants that inhibit Ras signaling and transformation and enhance cell adhesion.
Fiordalisi JJ; Holly SP; Johnson RL; Parise LV; Cox AD
J Biol Chem; 2002 Mar; 277(13):10813-23. PubMed ID: 11799108
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of rain, a novel Ras-interacting protein with a unique subcellular localization.
Mitin NY; Ramocki MB; Zullo AJ; Der CJ; Konieczny SF; Taparowsky EJ
J Biol Chem; 2004 May; 279(21):22353-61. PubMed ID: 15031288
[TBL] [Abstract][Full Text] [Related]
10. First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand.
Palmioli A; Sacco E; Abraham S; Thomas CJ; Di Domizio A; De Gioia L; Gaponenko V; Vanoni M; Peri F
Bioorg Med Chem Lett; 2009 Aug; 19(15):4217-22. PubMed ID: 19515561
[TBL] [Abstract][Full Text] [Related]
11. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts.
Ahn JH; Ahn SK; Lee M
Biochem Biophys Res Commun; 2012 Jan; 417(2):857-63. PubMed ID: 22206679
[TBL] [Abstract][Full Text] [Related]
12. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
[TBL] [Abstract][Full Text] [Related]
13. Extending the Lifetime of Native GTP-Bound Ras for Site-Resolved NMR Measurements: Quantifying the Allosteric Dynamics.
Chen X; Yao H; Wang H; Mao Y; Liu D; Long D
Angew Chem Int Ed Engl; 2019 Feb; 58(9):2730-2733. PubMed ID: 30681242
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.
Elad-Sfadia G; Haklai R; Balan E; Kloog Y
J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.
End DW; Smets G; Todd AV; Applegate TL; Fuery CJ; Angibaud P; Venet M; Sanz G; Poignet H; Skrzat S; Devine A; Wouters W; Bowden C
Cancer Res; 2001 Jan; 61(1):131-7. PubMed ID: 11196150
[TBL] [Abstract][Full Text] [Related]
16. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids.
Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A
J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.
Mori S; Satoh T; Koide H; Nakafuku M; Villafranca E; Kaziro Y
J Biol Chem; 1995 Dec; 270(48):28834-8. PubMed ID: 7499408
[TBL] [Abstract][Full Text] [Related]
18. p204 protein is a novel modulator of ras activity.
Ding B; Lengyel P
J Biol Chem; 2008 Feb; 283(9):5831-48. PubMed ID: 18165224
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity.
Maurer T; Garrenton LS; Oh A; Pitts K; Anderson DJ; Skelton NJ; Fauber BP; Pan B; Malek S; Stokoe D; Ludlam MJ; Bowman KK; Wu J; Giannetti AM; Starovasnik MA; Mellman I; Jackson PK; Rudolph J; Wang W; Fang G
Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5299-304. PubMed ID: 22431598
[TBL] [Abstract][Full Text] [Related]
20. Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activity.
Ishii N; Harada N; Joseph EW; Ohara K; Miura T; Sakamoto H; Matsuda Y; Tomii Y; Tachibana-Kondo Y; Iikura H; Aoki T; Shimma N; Arisawa M; Sowa Y; Poulikakos PI; Rosen N; Aoki Y; Sakai T
Cancer Res; 2013 Jul; 73(13):4050-4060. PubMed ID: 23667175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
